Optimal Vascular and Parenchymal Contrast Enhancement: The Current State of the Art

Radiologic Clinics of North America

Volumn 47, Issue 1, 2009, Pages 13-26

  Fleischmann, Dominik ^a   Kamaya, Aya ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiac CT; Computed tomography; Contrast medium enhancement; CT angiography; CT liver; CT pancreas

Indexed keywords

CONTRAST MEDIUM;

AGED; ARTERY; COMPREHENSION; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; DYNAMICS; FEMALE; FLOW RATE; HUMAN; INFORMATION PROCESSING; INJECTION; LIVER; LIVER INJURY; LIVER PARENCHYMA; MALE; MODULATION; MULTIDETECTOR COMPUTED TOMOGRAPHY; PANCREAS; PHYSIOLOGY; PRIORITY JOURNAL; REVIEW; TUBE;

ANGIOGRAPHY; CONTRAST MEDIA; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INJECTIONS, INTRAVENOUS; RADIOGRAPHIC IMAGE ENHANCEMENT; RADIOGRAPHIC IMAGE INTERPRETATION, COMPUTER-ASSISTED; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 58949098775     PISSN: 00338389     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rcl.2008.10.009     Document Type: Review

References (39)

1. Dawson P., and Blomley M.J. Contrast media as extracellular fluid space markers: adaptation of the central volume theorem. British Journal of Radiology 69 (1996) 717-722
2. Hill J.A., Winniford M., Cohen M.B., et al. Multicenter trial of ionic versus nonionic contrast media for cardiac angiography. The iohexol cooperative study. Am J Cardiol 72 (1993) 770
3. Katayama H., Yamaguchi K., Kozuka T., et al. Adverse reactions to ionic and nonionic contrast media. A report from the Japanese committee on the safety of contrast media. Radiology 175 (1990) 621
4. Palmer F.J. The RACR survey of intravenous contrast media reactions. Final report. Australas Radiol 32 (1988) 426
5. Wolf G.L., Arenson R.L., and Cross A.P. A prospective trial of ionic vs nonionic contrast agents in routine clinical practice: comparison of adverse effects. AJR Am J Roentgenol 152 (1989) 939
6. Hopper K.D. With helical CT, is nonionic contrast a better choice than ionic contrast for rapid and large IV bolus injections?. AJR Am J Roentgenol 166 (1996) 715
7. Manual on contrast media, version 6. Reston (VA): American College of Radiology; 2008.
8. Thomsen HS, editor. Contrast media: safety issues and user guidelines, 1st edition. (Medical radiology - diagnostic imaging and radiation oncology), New York: Springer; 2005.
9. Thomsen H.S., and Morcos S.K. Management of acute adverse reactions to contrast media. Eur Radiol 14 (2004) 476
10. Aspelin P., Aubry P., Fransson S.G., et al. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 348 (2003) 491
11. Barrett B.J., Katzberg R.W., Thomsen H.S., et al. Contrast-induced nephropathy in patients with chronic kidney disease undergoing computed tomography: a double-blind comparison of iodixanol and iopamidol. Invest Radiol 41 (2006) 815
12. Katzberg R.W., and Barrett B.J. Risk of iodinated contrast material-induced nephropathy with intravenous administration. Radiology 243 (2007) 622
13. Dawson P., and Blomley M.J. Contrast agent pharmacokinetics revisited: I. Reformulation. Acad Radiol 3 Suppl 2 (1996) S261
14. Fleischmann D. Present and future trends in multiple detector-row CT applications: CT angiography. Europ Radiol 12 (2002) S11
15. Claussen C.D., Banzer D., Pfretzschner C., et al. Bolus geometry and dynamics after intravenous contrast-medium injection. Radiology 153 (1984) 365
16. Fleischmann D., and Hittmair K. Mathematical analysis of arterial enhancement and optimization of bolus geometry for CT angiography using the discrete Fourier transform. J Comput Assist Tomogr 23 (1999) 474
17. Sheiman R.G., Raptopoulos V., Caruso P., et al. Comparison of tailored and empiric scan delays for CT angiography of the abdomen. AJR Am J Roentgenol 167 (1996) 725
18. Hittmair K., and Fleischmann D. Accuracy of predicting and controlling time-dependent aortic enhancement from a test bolus injection. J Comput Assist Tomogr 25 (2001) 287
19. Bae K.T., Heiken J.P., and Brink J.A. Aortic and hepatic contrast medium enhancement at CT. Part II. Effect of reduced cardiac output in a porcine model. Radiology 207 (1998) 657
20. Iannaccone R., Laghi A., Catalano C., et al. Hepatocellular carcinoma: role of unenhanced and delayed phase multi-detector row helical CT in patients with cirrhosis. Radiology 234 (2005) 460
21. Lim J.H., Choi D., Kim S.H., et al. Detection of hepatocellular carcinoma: value of adding delayed phase imaging to dual-phase helical CT. Am J Roentgenol 179 (2002) 67
22. Asayama Y., Yoshimitsu K., Irie H., et al. Delayed-phase dynamic CT enhancement as a prognostic factor for mass-forming intrahepatic cholangiocarcinoma. Radiology 238 (2005) 150
23. Keogan M.T., Seabourn J.T., Paulson E.K., et al. Contrast-enhanced CT of intrahepatic and hilar cholangiocarcinoma: delay time for optimal imaging. AJR Am J Roentgenol 169 (1997) 1493
24. Lacomis J., Baron R., Oliver III J., et al. Cholangiocarcinoma: delayed CT contrast enhancement patterns. Radiology 203 (1997) 98
25. Ho L.M., Nelson R.C., and Delong D.M. Determining contrast medium dose and rate on basis of lean body weight: does this strategy improve patient-to-patient uniformity of hepatic enhancement during multi-detector row CT?. Radiology 243 (2007) 431
26. Foley W.D., Mallisee T.A., Hohenwalter M.D., et al. Multiphase hepatic CT with a multirow detector CT scanner. AJR Am J Roentgenol 175 (2000) 679
27. Awai K., Takada K., Onishi H., et al. Aortic and hepatic enhancement and tumor-to-liver contrast: analysis of the effect of different concentrations of contrast material at multi-detector row helical CT. Radiology 224 (2002) 757
28. Schima W., Hammerstingl R., Catalano C., et al. Quadruple-phase MDCT of the liver in patients with suspected hepatocellular carcinoma: effect of contrast material flow rate. Am J Roentgenol 186 (2006) 1571
29. Schueller G., Schima W., Schueller-Weidekamm C., et al. Multidetector ct of pancreas: effects of contrast material flow rate and individualized scan delay on enhancement of pancreas and tumor contrast. Radiology 241 (2006) 441
30. Kondo H., Kanematsu M., Goshima S., et al. MDCT of the pancreas: optimizing scanning delay with a bolus-tracking technique for pancreatic, peripancreatic vascular, and hepatic contrast enhancement. Am J Roentgenol 188 (2007) 751
31. Yanaga Y., Awai K., Nakayama Y., et al. Pancreas: patient body weight tailored contrast material injection protocol versus fixed dose protocol at dynamic CT. Radiology 245 (2007) 475
32. Van Hoe L., Marchal G., Baert A.L., et al. Determination of scan delay-time in spiral CT-angiography: utility of a test bolus injection. J Comput Assist Tomogr 19 (1995) 216
33. Fleischmann D., Rubin G.D., Bankier A.A., et al. Improved uniformity of aortic enhancement with customized contrast medium injection protocols at CT angiography. Radiology 214 (2000) 363
34. Birnbaum B.A., Jacobs J.E., Langlotz C.P., et al. Assessment of a bolus-tracking technique in helical renal CT to optimize nephrographic phase imaging. Radiology 211 (1999) 87
35. Mastora I., Remy-Jardin M., Delannoy V., et al. Multi-detector row spiral CT angiography of the thoracic outlet: dose reduction with anatomically adapted online tube current modulation and preset dose savings. Radiology 230 (2004) 116
36. Rizzo S., Kalra M., Schmidt B., et al. Comparison of angular and combined automatic tube current modulation techniques with constant tube current ct of the abdomen and pelvis. Am J Roentgenol 186 (2006) 673
37. Fleischmann D, Rubin GD. Quantification of intravenously administered contrast medium transit through the peripheral arteries: implications for CT angiography. Radiology 2005;236:1076-82.
38. Fleischmann D., Hallett R.L., and Rubin G.D. CT angiography of peripheral arterial disease. J Vasc Interv Radiol 17 (2006) 3
39. Fleischmann D. Contrast-medium administration. In: Catalano C., and Passariello R. (Eds). Multidetector-row CT angiography (2005), Springer, Berlin, Heidelberg, New York 41